As an example, a bispecific aptamer (BiApt) targeting PD-1 and nucleolin, a protein which is highly expressed on the surface of multiple cancer cells, demonstrated promising results in a murine colon cancer model, effectively inhibiting tumor growth and enhancing T cell recruitment to the tumor site, boosting antitumor immunity (Table 1) [44]. Here, PDCD1 is linked to neoplasm.